<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20999" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hereditary Elliptocytosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jha</surname>
            <given-names>Suman K.</given-names>
          </name>
          <aff>B.P. Koirala Institute of Health Sciences</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vaqar</surname>
            <given-names>Sarosh</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Suman Jha declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sarosh Vaqar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20999.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Hereditary elliptocytosis encompasses a range of inherited red blood cell (RBC) membrane disorders characterized by elliptical-shaped RBCs. The condition is diverse, ranging from asymptomatic cases to severe hemolysis. Effective management involves tailoring interventions based on the severity of symptoms, with options including no treatment for asymptomatic individuals and splenectomy for severe cases.&#x000a0;</p>
        <p>Clinicians participating in this activity on&#x000a0;hereditary elliptocytosis can expect to gain a comprehensive understanding of the condition. The information covers the diverse spectrum of hereditary elliptocytosis, from asymptomatic cases to severe hemolysis, providing insights into the nuances of its presentation.&#x000a0;Furthermore, participants will glean insights into the collaborative approach involving an interprofessional team in evaluating and treating hereditary elliptocytosis, emphasizing the importance of a holistic perspective in patient care. Overall, this activity equips clinicians with the knowledge and skills needed to manage and navigate the complexities of hereditary elliptocytosis effectively.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify&#x000a0;the varying presentations of hereditary elliptocytosis, distinguishing between asymptomatic cases and those requiring intervention.</p></list-item><list-item><p>Select appropriate diagnostic tools and genetic testing methods for accurately identifying and classifying hereditary&#x000a0;elliptocytosis.</p></list-item><list-item><p>Implement tailored interventions based on the severity of hereditary&#x000a0;elliptocytosis symptoms, ranging from no treatment for asymptomatic cases to splenectomy for severe hemolysis.</p></list-item><list-item><p>Communicate effectively with patients, ensuring they comprehend the impact of hereditary&#x000a0;elliptocytosis on their quality of life and empowering them in their healthcare decisions.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20999&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20999">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20999.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Hereditary elliptocytosis, or hereditary ovalocytosis, is an inherited heterogeneous red blood cell (RBC) disorder characterized by elongated, oval, or elliptical-shaped&#x000a0;RBCs on the peripheral blood smear. Genetic alterations in&#x000a0;&#x003b1;-spectrin, &#x003b2;-spectrin, protein 4.1, band 3, and, rarely, glycophorin C result in the loss of the normal elastic recoil property&#x000a0;in RBCs&#x000a0;within&#x000a0;the peripheral circulation, resulting in&#x000a0;their distinctive elliptical shape.</p>
        <p>The spleen plays a crucial role in the manifestation of the disorder, as it captures and eliminates these abnormal&#x000a0;elliptocytes, ultimately causing hemolytic anemia. Elliptocytosis was first described by Dresbach in 1904, and its hereditary nature was firmly established by Hunter.</p>
        <p>Hereditary elliptocytosis encompasses various subtypes, each with distinct characteristics. These subtypes include common hereditary elliptocytosis, hereditary pyropoikilocytosis (HPP), Southeast Asian ovalocytosis (SAO), and spherocytic elliptocytosis (SE). The differentiation among these subtypes lies in variations in RBC morphology and the degree of hemolysis.</p>
        <p>The majority of individuals with&#x000a0;hereditary elliptocytosis are asymptomatic and, therefore, do not necessitate any specific treatment. However, for symptomatic patients, effective management may involve interventions such as blood transfusions and splenectomy.<xref ref-type="bibr" rid="article-20999.r1">[1]</xref><xref ref-type="bibr" rid="article-20999.r2">[2]</xref>&#x000a0;These approaches aim to address and alleviate the symptoms associated with the condition.</p>
      </sec>
      <sec id="article-20999.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The elastic deformability of RBCs is&#x000a0;primarily influenced&#x000a0;by the cytoskeleton proteins located&#x000a0;beneath the cell membrane. The&#x000a0;5 interconnected proteins&#x000a0;crucial to this process are spectrin, ankyrin, protein 4.2, band 3 protein, and glycophorin C. Any genetic abnormalities affecting these proteins can&#x000a0;alter their structure and function, resulting in abnormal&#x000a0;RBCs and&#x000a0;compromised deformability.</p>
        <p>Most&#x000a0;hereditary elliptocytosis cases are due to genetic defects&#x000a0;impacting &#x003b1;-spectrin,&#x000a0;&#x003b2;-spectrin, protein 4.1, band 3, and rarely glycophorin C.<xref ref-type="bibr" rid="article-20999.r3">[3]</xref>&#x000a0;These&#x000a0;genetic alterations include single base substitution, insertions, deletions, or changes in mRNA processing. The&#x000a0;genes associated with these mutations include&#x000a0;SPTA1 for &#x003b1;-spectrin, SPTB for &#x003b2;-spectrin, and EPB41 for protein 4.1. Among these, SPTA1 mutation is the most prevalent in hereditary elliptocytosis, occurring in 65% of cases, followed by mutations in SPTB (30%) and EPB41 (5%).</p>
        <p>Hereditary elliptocytosis typically follows an&#x000a0;autosomal dominant inheritance pattern, except HPP, which is inherited in an autosomal recessive manner.<xref ref-type="bibr" rid="article-20999.r4">[4]</xref><xref ref-type="bibr" rid="article-20999.r5">[5]</xref>&#x000a0;An &#x003b1;-spectrin mutation characterizes HPP juxtaposed in a transformation noted as &#x003b1;-LELY.<xref ref-type="bibr" rid="article-20999.r6">[6]</xref><xref ref-type="bibr" rid="article-20999.r7">[7]</xref></p>
      </sec>
      <sec id="article-20999.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The&#x000a0;prevalence of hereditary elliptocytosis remains uncertain, given that many individuals with mild symptoms often go undiagnosed. The estimated prevalence&#x000a0;ranges from 1 in 2000 to 1 in 4000 globally. Hereditary elliptocytosis is most commonly&#x000a0;observed in populations of African, Southeast Asian, or Mediterranean descent. In West Africa,&#x000a0;the prevalence&#x000a0;can&#x000a0;be as high as 1% to 2%, making it approximately 10 times more frequent in this region compared to Europe and the US.<xref ref-type="bibr" rid="article-20999.r8">[8]</xref>&#x000a0;</p>
        <p>Less than 10% of individuals with&#x000a0;hereditary elliptocytosis exhibit the more severe variant known as HPP. The geographical distribution&#x000a0;of&#x000a0;hereditary elliptocytosis aligns with&#x000a0;malaria-endemic areas,&#x000a0;suggesting that&#x000a0;malaria may have played a role in driving the expansion of the gene mutation associated with this condition.</p>
        <p>Specific hereditary elliptocytosis variants, such as&#x000a0;SAO, are particularly prevalent in&#x000a0;populations&#x000a0;from Malaysia,&#x000a0;Papua New Guinea, Indonesia, and the Philippines, with estimated prevalence rates ranging from&#x000a0;5% to 25%. On the other hand,&#x000a0;SE is&#x000a0;more commonly observed in individuals of European descent.<xref ref-type="bibr" rid="article-20999.r9">[9]</xref></p>
      </sec>
      <sec id="article-20999.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The normal RBC membrane&#x000a0;comprises&#x000a0;a lipid bilayer&#x000a0;and cytoskeleton proteins&#x000a0;crucial for maintaining membrane integrity and surface area. These cytoskeleton proteins&#x000a0;include spectrin (composed of &#x003b1; and &#x003b2; heterodimers), ankyrin, protein 4.1, protein 4.2, band 3, and glycophorin C. Genetic alterations affecting &#x003b1;-spectrin, &#x003b2;-spectrin, protein 4.1, band 3, and rarely glycophorin C result in defects in RBC membrane stability and deformability&#x000a0;during their passage through the microcirculation.</p>
        <p>Consequently, RBCs&#x000a0;struggle to regain their&#x000a0;normal biconcave shape&#x000a0;due to the loss of elastic recoil, resulting in a fixed morphology of elliptocytes in peripheral blood. These elliptocytes become entrapped and&#x000a0;eliminated by the spleen, resulting in the premature destruction of the RBCs (&#x0003c;120 days) and prominent intravascular hemolysis, a predominant feature in hereditary elliptocytosis.&#x000a0;The severity of anemia directly correlates with&#x000a0;the&#x000a0;degree&#x000a0;of reduction in RBC membrane stability.<xref ref-type="bibr" rid="article-20999.r10">[10]</xref><xref ref-type="bibr" rid="article-20999.r11">[11]</xref>&#x000a0;</p>
        <p>Individuals heterozygous for an elliptocytic variant typically remain asymptomatic. In contrast, those who are homozygous or compound heterozygous for&#x000a0;hereditary elliptocytosis variants may experience mild-to-severe anemia.</p>
        <p>The membranes in HPP are reportedly uniquely&#x000a0;susceptible to thermal stressors, exhibiting unique instability. In HPP, the &#x003b1;-spectrin&#x000a0;cannot&#x000a0;associate in dimeric form with the &#x003b2;-spectrin, disrupting the membrane cytoskeleton. This disturbance leads to a membrane elasticity loss, making it prone to hemolysis.&#x000a0;</p>
        <p>HPP is typically biallelic, unlike the monoallelic inheritance pattern observed in hereditary elliptocytosis. Individuals with HPP carry either a homozygous or compound heterozygous mutation, contributing to phenotypic heterogenicity.<xref ref-type="bibr" rid="article-20999.r3">[3]</xref><xref ref-type="bibr" rid="article-20999.r7">[7]</xref><xref ref-type="bibr" rid="article-20999.r12">[12]</xref>&#x000a0;The clinical polymorphism&#x000a0;observed in HPP reflects the genetic variations underlying the condition.</p>
      </sec>
      <sec id="article-20999.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Most cases of&#x000a0;hereditary elliptocytosis are asymptomatic and may be incidentally discovered during the investigation of anemia. However, some individuals may exhibit symptoms such as fatigue or reduced exercise tolerance due to anemia. It is essential to focus on anemia&#x000a0;within family members, as&#x000a0;hereditary elliptocytosis may be misdiagnosed as another condition like iron deficiency anemia. Rarely, hereditary elliptocytosis may present as neonatal jaundice.</p>
        <p>Long-standing hemolytic anemia&#x000a0;associated with&#x000a0;hereditary elliptocytosis can result in&#x000a0;splenomegaly, characterized by early satiety, left upper quadrant abdominal pain, and abdominal discomfort. Patients with HPP may display frontal bossing, while chronic hemolysis can lead to leg ulcers. The presentation varies among the different subtypes of hereditary elliptocytosis,&#x000a0;each of which is described below.</p>
        <p>Common&#x000a0;hereditary elliptocytosis represents the most prevalent form of hereditary elliptocytosis, and patients are typically asymptomatic. Neonates with this condition may&#x000a0;experience&#x000a0;transient hemolysis,&#x000a0;which&#x000a0;typically resolves within the first year of life. In cases of severe hemolytic anemia and jaundice in neonates, transfusion and phototherapy may be&#x000a0;necessary. The&#x000a0;defining characteristic of common&#x000a0;hereditary elliptocytosis is the presence of elliptical-shaped RBCs in the peripheral blood smear,&#x000a0;constituting anywhere from 15% to 100% of the total RBCs. The peripheral blood smear may also observe spherocytes, stomatocytes, and poikilocytes (fragmented cells).</p>
        <p>HPP stands out as the most severe form of hereditary elliptocytosis, predominantly affecting African-American neonates. These infants typically present with neonatal jaundice and persistent hemolytic anemia throughout their lives. The peripheral blood smear in HPP&#x000a0;reveals&#x000a0;poikilocytes and spherocytes with rare elliptocytes. Microspherocytes are present, with a mean corpuscular volume (MCV) of 30 to 50 gL. In some cases,&#x000a0;the&#x000a0;cellular morphology&#x000a0;may resemble those of thermal burn patients, displaying microspherocytes&#x000a0;and erythrocyte fragments.<xref ref-type="bibr" rid="article-20999.r13">[13]</xref>&#x000a0;</p>
        <p>Neonates affected by HPP often experience complications related to hemolysis, like splenomegaly and the formation of pigment gallstones, necessitating interventions like transfusion and splenectomy. Additionally, the profound hemolysis in neonates with HPP may lead to challenges such as an increased risk of severe anemia, emphasizing the importance of prompt and targeted medical interventions.</p>
        <p>SAO, also&#x000a0;called stomatocytosis elliptocytosis, is&#x000a0;predominantly&#x000a0;observed in regions endemic to&#x000a0;malaria. This condition is characterized by mild or no hemolysis and&#x000a0;provides resistance against&#x000a0;<italic toggle="yes">Plasmodium falciparum</italic>&#x000a0;infection. The peripheral blood smear of individuals with SAO&#x000a0;exhibits stomatocytes, ovalocytes, and macro-ovalocytes. The underlying cause of this entity is a deletion within the SLC441 gene that encodes erythrocyte band 3.<xref ref-type="bibr" rid="article-20999.r14">[14]</xref></p>
        <p>SE is frequently observed in individuals of&#x000a0;Italian&#x000a0;descent and is associated&#x000a0;with mild to moderate hemolysis. Distinguishing between HS and&#x000a0;hereditary elliptocytosis using ektacytometry&#x000a0;can be effective, but challenges may arise in the presence of&#x000a0;HPP. The intricate pattern of ektacytometry and morphological features of HPP may pose difficulties for differentiation. In such cases, genetic analysis can&#x000a0;provide&#x000a0;valuable assistance <xref ref-type="bibr" rid="article-20999.r7">[7]</xref>.&#x000a0;</p>
        <p>Physical examination findings in&#x000a0;hereditary elliptocytosis include pallor in&#x000a0;individuals undergoing hemolysis and observable signs such as splenomegaly. Additionally, right upper quadrant pain may be present in patients with gallstones related to hemolysis.<xref ref-type="bibr" rid="article-20999.r15">[15]</xref><xref ref-type="bibr" rid="article-20999.r16">[16]</xref></p>
      </sec>
      <sec id="article-20999.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The evaluation of&#x000a0;hereditary elliptocytosis is initiated with a comprehensive assessment, including a&#x000a0;complete blood count (CBC) revealing normocytic normochromic anemia. A peripheral blood smear is essential, typically&#x000a0;demonstrating elliptocytes in&#x000a0;15% to 100% of RBCs, along with other variations, such as spherocytes, stomatocytes, poikilocytes, ovalocytes, and macro-ovalocytes. Testing for hemolysis reveals features of extravascular hemolysis characterized by an elevated reticulocyte count, increased lactate dehydrogenase, indirect bilirubin, and decreased haptoglobin level. The predominance of elliptocytes does not consistently correlate with the severity of hemolysis. Polychromasia is expected with&#x000a0;hemolysis and reticulocytosis.&#x000a0;</p>
        <p>For a more detailed analysis, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) can quantify protein 4.1 and spectrin. Additionally, morphologic and genetic studies are completed by ektacytometry, which reveals characteristic responses of the&#x000a0;erythrocyte membrane to laser diffraction and biomechanical stressors.<xref ref-type="bibr" rid="article-20999.r17">[17]</xref>&#x000a0;</p>
        <p>In cases where&#x000a0;splenomegaly is suspected, ultrasonography is the&#x000a0;preferred and cost-effective diagnostic tool. Computed tomography (CT) and magnetic resonance imaging (MRI) may also be utilized for further investigation.&#x000a0;</p>
      </sec>
      <sec id="article-20999.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Asymptomatic individuals without hemolysis do not require treatment&#x000a0;or regular&#x000a0;follow-up. The priority is to educate the patient about the nature of the disease and ensure proper documentation&#x000a0;in the&#x000a0;patient's records to prevent unnecessary testing.&#x000a0;</p>
        <p>Individuals&#x000a0;experiencing intermittent hemolysis or anemia may&#x000a0;necessitate blood transfusions when symptomatic or&#x000a0;when their hemoglobin level&#x000a0;falls below the age-specific threshold. Splenectomy is&#x000a0;considered for patients facing severe, life-threatening anemia or requiring regular blood transfusions.&#x000a0;However, vaccination against pneumococcus, meningococcus, and <italic toggle="yes">Haemophilus influenza</italic> is&#x000a0;mandatory&#x000a0;before&#x000a0;surgery due to the associated heightened risk of infection with encapsulated organisms.</p>
      </sec>
      <sec id="article-20999.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of hereditary elliptocytosis includes various conditions:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hereditary spherocytosis</p>
          </list-item>
          <list-item>
            <p>Glucose-6-phosphate dehydrogenase (G6PD) deficiency</p>
          </list-item>
          <list-item>
            <p>Thalassemia: Coinheritanced with&#x000a0;hereditary elliptocytosis may present as a non-transfusion-dependent patient with marked poikilocytosis and fragmented cells.<xref ref-type="bibr" rid="article-20999.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p>Pyruvate kinase deficiency</p>
          </list-item>
          <list-item>
            <p>Hereditary stomatocytosis/xerocytosis</p>
          </list-item>
          <list-item>
            <p>Iron deficiency anemia</p>
          </list-item>
          <list-item>
            <p>Megaloblastic anemia</p>
          </list-item>
          <list-item>
            <p>Sickle cell anemia</p>
          </list-item>
          <list-item>
            <p>Myelofibrosis</p>
          </list-item>
          <list-item>
            <p>Myelodysplastic syndrome, although rare, acquired elliptocytosis can arise&#x000a0;in a myelodysplastic setting.<xref ref-type="bibr" rid="article-20999.r18">[18]</xref><xref ref-type="bibr" rid="article-20999.r19">[19]</xref>&#x000a0;The most common genetic defect of HE/MDS is del20q.<xref ref-type="bibr" rid="article-20999.r18">[18]</xref>&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20999.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Most patients with&#x000a0;hereditary elliptocytosis are asymptomatic, and only a small percentage (5%-20%) experience uncompensated hemolysis&#x000a0;leading to anemia. Even&#x000a0;among those with&#x000a0;severe hemolysis who undergo treatment with splenectomy, the prognosis is generally favorable, emphasizing the overall benign course of the condition.</p>
      </sec>
      <sec id="article-20999.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications associated with&#x000a0;hereditary elliptocytosis include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Megaloblastic anemia may result from folate and Vitamin B12 deficiency&#x000a0;due to chronic hemolysis. The&#x000a0;deficiency&#x000a0;may arise from nutritional factors, functional issues related to significant erythrocyte production, or a combination.<xref ref-type="bibr" rid="article-20999.r20">[20]</xref>&#x000a0;Supplementation with vitamin B12 or folate can help alleviate this issue.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pigment gallstones: May lead to complications such as cholangitis, cholecystitis, and pancreatitis.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Splenomegaly: Patients&#x000a0;may experience functional&#x000a0;and moderate splenomegaly similar to many hemolytic anemias.<xref ref-type="bibr" rid="article-20999.r21">[21]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Renal tubular acidosis: Associated with SAO, wherein familial distal renal tubular acidosis is associated with&#x000a0;this specific subtype.<xref ref-type="bibr" rid="article-20999.r22">[22]</xref>.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Leg ulcers: Typically&#x000a0;form around the&#x000a0;medial malleoli, which are thought to occur in hemolytic anemias due to stasis.<xref ref-type="bibr" rid="article-20999.r23">[23]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Growth retardation and skeletal abnormalities: May develop due to marrow expansion.<xref ref-type="bibr" rid="article-20999.r24">[24]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20999.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>&#x000a0;While consultations with a specialist may not always be necessary, referrals to specific consultants may be required in certain circumstances and can include:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>General surgeon: Particularly for patients&#x000a0;contemplating splenectomy.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Genetic counselor: To&#x000a0;provide comprehensive explanations about the genetic transmission of the&#x000a0;disease.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hematologist:&#x000a0;This referral may be beneficial for perioperative assessment, administration of Vitamin B12 or folate, and engagement in transfusional therapy if required.&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20999.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Educating patients and their family members about the autosomal dominant and recessive modes of inheritance associated with&#x000a0;hereditary elliptocytosis is crucial. Family members should undergo screening for hereditary elliptocytosis, and parents of severely affected children should be offered prenatal counseling. Patients who have undergone splenectomy, prophylactic vaccination, and regular follow-up are essential to monitor for potential complications. Given the significant morbidity associated with hereditary elliptocytosis, equal attention should be given to the next generation as to the present one.</p>
      </sec>
      <sec id="article-20999.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Some key points to be aware of about&#x000a0;hereditary elliptocytosis include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hereditary elliptocytosis exhibits genetic heterogeneity, with various mutations affecting proteins involved in RBC membrane structure.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Most individuals with&#x000a0;hereditary elliptocytosis are asymptomatic, and the condition is often discovered incidentally during anemia workup.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Treatment varies based on the severity of symptoms, ranging from no intervention for asymptomatic cases to splenectomy for those with severe hemolysis.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>For severe cases, splenectomy may be considered but requires careful consideration due to potential complications, necessitating vaccination and follow-up.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hereditary elliptocytosis can be misdiagnosed as other anemias, emphasizing the need for accurate diagnostic tools and genetic testing.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>While splenectomy can alleviate symptoms, it carries an increased risk of infection, necessitating precautions.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Educating patients and families about the autosomal dominant or recessive inheritance patterns is crucial.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Regular screening of family members, especially those with a family history of anemia, aids in early detection.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20999.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Hereditary elliptocytosis is a rare genetic disorder characterized by elliptically shaped red blood cells, leading to hemolytic anemia. The&#x000a0;presentation of hereditary elliptocytosis varies widely, from asymptomatic cases to those with severe hemolysis. Clinicians should recognize the distinctive elliptocytes on blood smear examination and confirm the diagnosis through specialized laboratory tests. A&#x000a0;heightened level&#x000a0;of suspicion is essential, particularly in patients with normocytic normochromic anemia and a family history of anemia. While most individuals with hereditary elliptocytosis are asymptomatic, some may experience mild-to-moderate anemia.</p>
        <p>Management involves monitoring for complications, particularly during infections or pregnancy, and supportive care for symptomatic cases. Genetic counseling is essential for families, as hereditary elliptocytosis inheritance patterns vary. Regular follow-up and patient education contribute to optimized care. In severe cases, splenectomy may be considered. A comprehensive understanding of hereditary elliptocytosis aids clinicians in providing tailored care, addressing potential complications, and offering appropriate genetic counseling to affected individuals and their families. Optimal management of a patient diagnosed with hereditary elliptocytosis necessitates the collaboration of an interprofessional team to improve outcomes. Acknowledging that, in hereditary conditions, the family plays a pivotal role in the patient's experience and underscores the significance of a comprehensive and holistic approach to healthcare.</p>
      </sec>
      <sec id="article-20999.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20999&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20999">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/blood-disorders/hereditary-elliptocytosis-hereditary-ovalocytosis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20999">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20999/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20999">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-20999.s17">
        <title>References</title>
        <ref id="article-20999.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mohandas</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Inherited hemolytic anemia: a possessive beginner's guide.</article-title>
            <source>Hematology Am Soc Hematol Educ Program</source>
            <year>2018</year>
            <month>Nov</month>
            <day>30</day>
            <volume>2018</volume>
            <issue>1</issue>
            <fpage>377</fpage>
            <page-range>377-381</page-range>
            <pub-id pub-id-type="pmid">30504335</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iolascon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Andolfo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Advances in understanding the pathogenesis of red cell membrane disorders.</article-title>
            <source>Br J Haematol</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>187</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-24</page-range>
            <pub-id pub-id-type="pmid">31364155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anil More</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kedar</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Unravelling the genetic and phenotypic heterogeneity of SPTA1 gene variants in Hereditary Elliptocytosis and Hereditary Pyropoikilocytosis patients using next-generation sequencing.</article-title>
            <source>Gene</source>
            <year>2022</year>
            <month>Nov</month>
            <day>15</day>
            <volume>843</volume>
            <fpage>146796</fpage>
            <pub-id pub-id-type="pmid">35961434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic approaches for inherited hemolytic anemia in the genetic era.</article-title>
            <source>Blood Res</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>52</volume>
            <issue>2</issue>
            <fpage>84</fpage>
            <page-range>84-94</page-range>
            <pub-id pub-id-type="pmid">28698843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>Q</given-names>
              </name>
            </person-group>
            <article-title>Hereditary elliptocytosis with variable expression and incomplete penetrance in a Chinese family.</article-title>
            <source>Br J Haematol</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>186</volume>
            <issue>5</issue>
            <fpage>e159</fpage>
            <page-range>e159-e162</page-range>
            <pub-id pub-id-type="pmid">31168794</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maillet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Alloisio</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Morl&#x000e9;</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Delaunay</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Spectrin mutations in hereditary elliptocytosis and hereditary spherocytosis.</article-title>
            <source>Hum Mutat</source>
            <year>1996</year>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>97</fpage>
            <page-range>97-107</page-range>
            <pub-id pub-id-type="pmid">8844207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vives-Corrons</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Krishnevskaya</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hern&#x000e1;ndez-Rodriguez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pay&#x000e1;n-Pernia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sevilla</surname>
                <given-names>&#x000c1;FR</given-names>
              </name>
              <name>
                <surname>Badell</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Red cell ektacytometry in two patients with chronic hemolytic anemia and three new &#x003b1;-spectrin variants.</article-title>
            <source>Ann Hematol</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>101</volume>
            <issue>3</issue>
            <fpage>549</fpage>
            <page-range>549-555</page-range>
            <pub-id pub-id-type="pmid">34845540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lecomte</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Dhermy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gautero</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bournier</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Galand</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Boivin</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[Hereditary elliptocytosis in West Africa: frequency and repartition of spectrin variants].</article-title>
            <source>C R Acad Sci III</source>
            <year>1988</year>
            <volume>306</volume>
            <issue>2</issue>
            <fpage>43</fpage>
            <page-range>43-6</page-range>
            <pub-id pub-id-type="pmid">3126987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andolfo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Russo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gambale</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Iolascon</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>New insights on hereditary erythrocyte membrane defects.</article-title>
            <source>Haematologica</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>101</volume>
            <issue>11</issue>
            <fpage>1284</fpage>
            <page-range>1284-1294</page-range>
            <pub-id pub-id-type="pmid">27756835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ou</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Spectrin-based membrane skeleton supports ciliogenesis.</article-title>
            <source>PLoS Biol</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>17</volume>
            <issue>7</issue>
            <fpage>e3000369</fpage>
            <pub-id pub-id-type="pmid">31299042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Risinger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Christakopoulos</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Schultz</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>McGann</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Kalfa</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Hereditary elliptocytosis-associated alpha-spectrin mutation p.L155dup as a modifier of sickle cell disease severity.</article-title>
            <source>Pediatr Blood Cancer</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>66</volume>
            <issue>2</issue>
            <fpage>e27531</fpage>
            <pub-id pub-id-type="pmid">30393954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>S&#x000e1;nchez Villalobos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salido Fi&#x000e9;rrez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez Nieto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a Garay</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Beltr&#x000e1;n Videla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez Oliva</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Blanquer Blanquer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moraleda Jim&#x000e9;nez</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Case Report: &#x003b1;-Spectrin Mutation Associated with &#x003b1;LELY Polymorphism Responsible for Hereditary Pyropoikilocytosis.</article-title>
            <source>Hematol Rep</source>
            <year>2022</year>
            <month>Oct</month>
            <day>08</day>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>300</fpage>
            <page-range>300-304</page-range>
            <pub-id pub-id-type="pmid">36278520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bayhan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>&#x000dc;nal</surname>
                <given-names>&#x0015e;</given-names>
              </name>
              <name>
                <surname>G&#x000fc;mr&#x000fc;k</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Hereditary Elliptocytosis with Pyropoikilocytosis.</article-title>
            <source>Turk J Haematol</source>
            <year>2016</year>
            <month>Mar</month>
            <day>05</day>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>86</fpage>
            <page-range>86-7</page-range>
            <pub-id pub-id-type="pmid">26377499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garnett</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bain</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>South-East Asian ovalocytosis.</article-title>
            <source>Am J Hematol</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>88</volume>
            <issue>4</issue>
            <fpage>328</fpage>
            <pub-id pub-id-type="pmid">23339107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zaidi</surname>
                <given-names>AU</given-names>
              </name>
              <name>
                <surname>Buck</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gadgeel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Herrera-Martinez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bagla</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Ravindranath</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Clinical Diagnosis of Red Cell Membrane Disorders: Comparison of Osmotic Gradient Ektacytometry and Eosin Maleimide (EMA) Fluorescence Test for Red Cell Band 3 (AE1, SLC4A1) Content for Clinical Diagnosis.</article-title>
            <source>Front Physiol</source>
            <year>2020</year>
            <volume>11</volume>
            <fpage>636</fpage>
            <pub-id pub-id-type="pmid">32636758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bahr</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Lozano-Chinga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Meznarich</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Gerday</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Smoot</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Christensen</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Dizygotic twins with prolonged jaundice and microcytic, hypochromic, hemolytic anemia with pyropoikilocytosis.</article-title>
            <source>Blood Cells Mol Dis</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>85</volume>
            <fpage>102462</fpage>
            <pub-id pub-id-type="pmid">32623341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niss</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Chonat</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dagaonkar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Almansoori</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Kerr</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>ZR</given-names>
              </name>
              <name>
                <surname>McGann</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Quarmyne</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Risinger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kalfa</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis.</article-title>
            <source>Blood Cells Mol Dis</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>61</volume>
            <fpage>4</fpage>
            <page-range>4-9</page-range>
            <pub-id pub-id-type="pmid">27667160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kjelland</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Dwyre</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Jonas</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia.</article-title>
            <source>Case Rep Hematol</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>3625946</fpage>
            <pub-id pub-id-type="pmid">29158926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Risoluti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Caprari</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gullifa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sorrentino</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Maffei</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Massimi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carcassi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Materazzi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Differential diagnosis of hereditary hemolytic anemias in a single multiscreening test by TGA/chemometrics.</article-title>
            <source>Chem Commun (Camb)</source>
            <year>2020</year>
            <month>Jul</month>
            <day>14</day>
            <volume>56</volume>
            <issue>55</issue>
            <fpage>7557</fpage>
            <page-range>7557-7560</page-range>
            <pub-id pub-id-type="pmid">32555869</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Socha</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>DeSouza</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Flagg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sekeres</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Severe megaloblastic anemia: Vitamin deficiency and other causes.</article-title>
            <source>Cleve Clin J Med</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>87</volume>
            <issue>3</issue>
            <fpage>153</fpage>
            <page-range>153-164</page-range>
            <pub-id pub-id-type="pmid">32127439</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lv</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>WY</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Gong</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Hypersplenism: History and current status.</article-title>
            <source>Exp Ther Med</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>2377</fpage>
            <page-range>2377-2382</page-range>
            <pub-id pub-id-type="pmid">27703501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gunaratne</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Dissanayake</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jayaratne</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Premawardhana</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Siribaddana</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A case series of distal renal tubular acidosis, Southeast Asian ovalocytosis and metabolic bone disease.</article-title>
            <source>BMC Nephrol</source>
            <year>2020</year>
            <month>Aug</month>
            <day>05</day>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>327</fpage>
            <pub-id pub-id-type="pmid">32758154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sawhney</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Weedon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gillette</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Braverman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Predilection of hemolytic anemia-associated leg ulcers for the medial malleolus.</article-title>
            <source>Vasa</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>191</fpage>
            <page-range>191-3</page-range>
            <pub-id pub-id-type="pmid">12236024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20999.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Warang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kedar</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Hereditary Elliptocytosis: A Rare Red Cell Membrane Disorder.</article-title>
            <source>Indian J Hematol Blood Transfus</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>754</fpage>
            <page-range>754-755</page-range>
            <pub-id pub-id-type="pmid">30369757</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
